Literature DB >> 2333510

Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor Xa.

L Waxman1, D E Smith, K E Arcuri, G P Vlasuk.   

Abstract

A low molecular weight serine protease inhibitor (TAP) was purified from extracts of the soft tick, Ornithodoros moubata. The peptide is a slow, tight-binding inhibitor, specific for factor Xa (Ki = 0.588 +/- 0.054 nM). The inhibitor also acts as an anticoagulant in several human plasma clotting assays in vitro. Its amino acid sequence (60 residues) has limited homology to the Kunitz-type inhibitors. However, unlike other inhibitors of this class, TAP inhibits only factor Xa. It had no effect at a 300-fold molar excess on factor VIIa, kallikrein, trypsin, chymotrypsin, thrombin, urokinase, plasmin, tissue plasminogen activator, elastase, or Staphylococcus aureus V8 protease. TAP's specificity and size suggest that it may have therapeutic value as an anticoagulant.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2333510     DOI: 10.1126/science.2333510

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  76 in total

1.  Enhancing Thrombolysis with Adjunctive Therapy.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

Review 2.  Advances in thrombolytic therapy.

Authors:  M Verstraete
Journal:  Cardiovasc Drugs Ther       Date:  1992-04       Impact factor: 3.727

3.  Development of the salivary glands in embryos of Ixodes ricinus (Acari: Ixodidae).

Authors:  Krzysztof Jasik; Alicja Buczek
Journal:  Exp Appl Acarol       Date:  2004       Impact factor: 2.132

Review 4.  Tick saliva in anti-tick immunity and pathogen transmission.

Authors:  L Kovár
Journal:  Folia Microbiol (Praha)       Date:  2004       Impact factor: 2.099

5.  Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells.

Authors:  G P Gasic; C P Arenas; T B Gasic; G J Gasic
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

Review 6.  The pharmacological landscape and therapeutic potential of serine hydrolases.

Authors:  Daniel A Bachovchin; Benjamin F Cravatt
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

Review 7.  The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor.

Authors:  Elisabeth Perzborn; Susanne Roehrig; Alexander Straub; Dagmar Kubitza; Frank Misselwitz
Journal:  Nat Rev Drug Discov       Date:  2010-12-17       Impact factor: 84.694

8.  Mechanisms and specificity of factor XIa and trypsin inhibition by protease nexin 2 and basic pancreatic trypsin inhibitor.

Authors:  Duraiswamy Navaneetham; Dipali Sinha; Peter N Walsh
Journal:  J Biochem       Date:  2010-07-20       Impact factor: 3.387

9.  The transcriptome of the salivary glands of the female western black-legged tick Ixodes pacificus (Acari: Ixodidae).

Authors:  Ivo M B Francischetti; Van My Pham; Ben J Mans; John F Andersen; Thomas N Mather; Robert S Lane; José M C Ribeiro
Journal:  Insect Biochem Mol Biol       Date:  2005-10       Impact factor: 4.714

10.  Ancylostoma caninum anticoagulant peptide: a hookworm-derived inhibitor of human coagulation factor Xa.

Authors:  M Cappello; G P Vlasuk; P W Bergum; S Huang; P J Hotez
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-20       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.